| scholarly article | Q13442814 |
| P2093 | author name string | Y Matsuda | |
| T Ishiwata | |||
| M Korc | |||
| E Uchida | |||
| J Ueda | |||
| Z Naito | |||
| K Yamahatsu | |||
| P2860 | cites work | Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors | Q24302929 |
| ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing | Q24321530 | ||
| Exon Switching and Activation of Stromal and Embryonic Fibroblast Growth Factor (FGF)-FGF Receptor Genes in Prostate Epithelial Cells Accompany Stromal Independence and Malignancy | Q24602640 | ||
| Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 | ||
| The pancreas cancer microenvironment | Q27026705 | ||
| An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype | Q27339197 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Alternative isoform regulation in human tissue transcriptomes | Q27861118 | ||
| IQGAP1 regulation and roles in cancer | Q28237517 | ||
| Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells | Q28582736 | ||
| Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing | Q29547470 | ||
| Complex networks orchestrate epithelial-mesenchymal transitions | Q29547478 | ||
| Microenvironmental regulation of metastasis | Q29547660 | ||
| Metastasis: from dissemination to organ-specific colonization | Q29614295 | ||
| EMT and dissemination precede pancreatic tumor formation | Q29615854 | ||
| Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways | Q29615855 | ||
| Pancreatic cancer | Q29616288 | ||
| Expression cDNA Cloning of the KGF Receptor by Creation of a Transforming Autocrine Loop | Q33332072 | ||
| The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events | Q33661198 | ||
| Genetics and biology of pancreatic ductal adenocarcinoma. | Q34567515 | ||
| CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression | Q34627193 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Update on pancreatic intraepithelial neoplasia. | Q34826200 | ||
| Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma | Q35587710 | ||
| Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer | Q35753204 | ||
| Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer | Q35855631 | ||
| ZEB1-responsive genes in non-small cell lung cancer | Q35915752 | ||
| Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation | Q35951834 | ||
| RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer | Q36347682 | ||
| Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors | Q36436933 | ||
| Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase | Q36646357 | ||
| FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies | Q37456169 | ||
| The role of fibroblast growth factors in tumor growth | Q37512303 | ||
| Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells | Q38294589 | ||
| Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice | Q38298590 | ||
| RKIP and 14-3-3ε exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently | Q39296228 | ||
| Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis | Q39589877 | ||
| An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition | Q39667327 | ||
| Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma | Q39914383 | ||
| hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc | Q39969006 | ||
| Heterogeneous ribonucleoprotein m is a splicing regulatory protein that can enhance or silence splicing of alternatively spliced exons | Q40062835 | ||
| Role of growth factors in pancreatic cancer. | Q41690572 | ||
| Integrin-linked kinase controls microtubule dynamics required for plasma membrane targeting of caveolae | Q42066604 | ||
| Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer. | Q42465155 | ||
| Very alkaline immobilized pH gradients for two-dimensional electrophoresis of ribosomal and nuclear proteins | Q73338912 | ||
| Recent developments in two-dimensional gel electrophoresis with immobilized pH gradients: wide pH gradients up to pH 12, longer separation distances and simplified procedures | Q77798932 | ||
| Understanding metastasis in pancreatic cancer: a call for new clinical approaches | Q83296482 | ||
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 4485-4495 | |
| P577 | publication date | 2013-09-30 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases | |
| P478 | volume | 33 |
| Q61448581 | A novel alternative splicing-based prediction model for uteri corpus endometrial carcinoma |
| Q34994626 | A posttranscriptional mechanism that controls Ptbp1 abundance in the Xenopus epidermis |
| Q38994370 | Aberrant Splicing in Cancer: Mediators of Malignant Progression through an Imperfect Splice Program Shift |
| Q47823632 | Analysis of somatic microsatellite indels identifies driver events in human tumors. |
| Q83227835 | Androgen-regulated transcription of drives alternative splicing patterns in prostate cancer |
| Q48053117 | CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy |
| Q38924208 | Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer |
| Q57908393 | Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT |
| Q46518039 | Dual Roles for Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) in Cancer Progression |
| Q39109931 | EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression |
| Q92290218 | ESRP1 Induces Cervical Cancer Cell G1-Phase Arrest Via Regulating Cyclin A2 mRNA Stability |
| Q47138140 | ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells |
| Q92215247 | Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture |
| Q36319724 | Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer |
| Q37687476 | Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer |
| Q38964131 | Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms. |
| Q90266827 | Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer |
| Q92282798 | Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer |
| Q48318565 | Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells |
| Q46236135 | MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. |
| Q99609815 | Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma |
| Q92808657 | Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells |
| Q38656079 | RNA-Binding Proteins in Cancer: Old Players and New Actors. |
| Q51759222 | Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis. |
| Q38709877 | SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells |
| Q37709301 | Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer |
| Q40368929 | The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma |
| Q41991370 | The ESRP1-GPR137 axis contributes to intestinal pathogenesis. |
| Q41835902 | The RNA-binding protein ESRP1 promotes human colorectal cancer progression |
| Q54110894 | The biology and role of CD44 in cancer progression: therapeutic implications. |
| Q35108922 | Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonization |
Search more.